What is Costochondritis?
Costochondritis is a benign, self-limiting inflammation of the costochondral junctions (where ribs meet costal cartilage) or chondrosternal joints (where costal cartilages meet the sternum), characterized by reproducible chest wall tenderness on palpation—it is a diagnosis of exclusion after ruling out life-threatening cardiac, pulmonary, and vascular causes. 1, 2
Clinical Presentation
- Pain characteristics: Typically described as stinging (53%) or pressing (35%), most commonly retrosternal (52%) or left-sided (69%), affecting ribs 2-7 3
- Hallmark finding: Reproducible tenderness to palpation of the affected costochondral or chondrosternal joints 2, 4
- Temporal pattern: Symptoms often occur more than once daily (63%), with many patients experiencing chronic symptoms lasting >6 months (55%) 3
- Pain behavior: Sharp, stabbing pain that worsens with inspiration, palpation, or chest wall movement markedly reduces the probability of cardiac ischemia 2
Critical Differentiation from Life-Threatening Causes
Before diagnosing costochondritis, you must exclude acute coronary syndrome, aortic dissection, pulmonary embolism, and esophageal rupture—particularly in patients >35 years or with cardiac risk factors. 2, 4
Red Flags Requiring Immediate Cardiac Evaluation
- Severe prolonged chest pain of acute onset (unless clearly traumatic) requires immediate hospital care 1
- Associated symptoms: Cold sweat, nausea, vomiting, syncope, anxiety/fear indicate potential serious pathology 1
- Pain that interrupts normal activity warrants urgent evaluation 1
- Age >35 years or any cardiac risk factors: Obtain ECG within 10 minutes 2, 4
Features Suggesting Benign Musculoskeletal Origin
- Pain affected by palpation, breathing, turning, twisting, or bending has the highest diagnostic value against angina 1
- Pain generated from multiple sites or well-localized on the chest wall 1
- Pain that varies with body position or food intake 1
- Accompanied by local tenderness on examination 1
Critical Pitfall to Avoid
Do not use nitroglycerin response as a diagnostic criterion—relief with nitroglycerin does not distinguish cardiac from non-cardiac chest pain. 2 Additionally, coronary artery disease is present in 3-6% of adult patients with chest pain and chest wall tenderness, so serious cardiac conditions can coexist with musculoskeletal findings 2, 4.
Diagnostic Approach
Initial Assessment
- History and physical examination: Document reproducible pain by palpation over costal cartilages—this is usually sufficient in children, adolescents, and young adults 4
- ECG: Mandatory within 10 minutes for patients >35 years or with cardiac risk factors 2, 4
- Chest radiography: Useful as initial imaging to exclude rib fractures, infection, or neoplasm, though it may miss costochondral abnormalities 3
Advanced Imaging (When Indicated)
- Ultrasound: Higher sensitivity than CT for detecting costochondral involvement 3
- Bone scintigraphy: Highly sensitive (100%) for detecting sternoclavicular joint inflammation and osseocartilaginous disease, though insufficient specificity to differentiate inflammatory processes from bone tumors 3
- CT with 3D reconstructions: Higher sensitivity and specificity for differentiating primary chest wall tumors from Tietze syndrome 3
- MRI: Useful for evaluating extent of disease and detecting systemic inflammatory conditions 1
Important Differential Diagnoses
- Tietze syndrome: Localized inflammation with visible swelling at the costochondral junction—this is distinct from costochondritis 1, 5, 3
- Sternoclavicular joint inflammation: NOT costochondritis—consider spondyloarthritis, SAPHO syndrome, septic arthritis, or rheumatoid arthritis 5, 3
- Slipping rib syndrome: Pain associated with ribs subluxing from the joint 3
- Spondyloarthritis: Costochondritis affects 30-60% of patients with axial spondyloarthritis and may be the first disease manifestation 3
Management
First-Line Pharmacological Treatment
Initiate a 1-2 week course of NSAIDs for pleuritic-type pain or when there is an underlying inflammatory component. 2
- NSAIDs: First-line therapy for 1-2 weeks 2
- Acetaminophen: Alternative if NSAIDs are contraindicated 2
- Topical analgesics: Lidocaine patches provide localized pain relief with minimal systemic effects 2
Second-Line Options for Refractory Cases
- Low-dose colchicine: Add if symptoms persist despite NSAID therapy 2
- Local corticosteroid injections: Consider for refractory cases directed to the affected costochondral junction 3
- Analgesics (tramadol): Can be added for residual pain when NSAIDs are insufficient or contraindicated 3
Non-Pharmacological Approaches
- Ice packs or heat application: Use in conjunction with drug therapy 2
- Stretching exercises: Progressive significant improvement demonstrated in clinical trials (p<0.001) 6
- Osteopathic manipulation techniques: May be useful for rib dysfunction, especially in atypical costochondritis 7
- Activity modification: Advise patients to avoid activities that produce chest muscle overuse 4
Critical Management Pitfalls
Do not use systemic corticosteroids for isolated costochondritis—there is no evidence supporting their use. 3
Monitoring and Follow-Up
- Reassessment: Required to rule out other potential causes if pain persists beyond expected self-limited course 2
- Typical course: Usually self-limited and resolves in a couple of weeks 7, 4
- Atypical costochondritis: Pain persisting beyond typical timeframe requires multimodal approach and consideration of alternative diagnoses 7
Special Populations
- Spondyloarthritis patients: Multimodal therapy including cognitive behavioral therapy and low-dose amitriptyline for fibromyalgia overlap 3
- Inflammatory arthritis patients: NSAIDs remain first-line but monitor disease activity with composite measures 3
- Post-radiation patients: Chest wall edema, cortical thinning, and osteosclerosis may precede rib fractures (average 21 months post-therapy) 1